Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Zentiva Pharma UK Limited, 12 New Fetter Lane, London, EC4A 1JP, United Kingdom
Caspofungin Zentiva 50 mg powder for concentrate for solution for infusion.
| Pharmaceutical Form |
|---|
|
Powder for concentrate for solution for infusion. White to off-white lyophilized powder. |
Each 50 mg vial contains 50 mg caspofungin (as acetate).
After reconstitution in 10.5 ml of water for injection, 1 ml of the concentrate contains 5.2 mg caspofungin.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Caspofungin |
Caspofungin acetate is a semi-synthetic lipopeptide (echinocandin) compound synthesised from a fermentation product of Glarea lozoyensis. Caspofungin acetate inhibits the synthesis of beta (1,3)-D-glucan, an essential component of the cell wall of many filamentous fungi and yeast. Beta (1,3)-D-glucan is not present in mammalian cells. |
| List of Excipients |
|---|
|
Sucrose |
10 ml transparent Type I glass vial with grey bromobutyl rubber stopper and aluminium band with red PP flip-off cap.
Supplied in packs of 1 vial.
Zentiva Pharma UK Limited, 12 New Fetter Lane, London, EC4A 1JP, United Kingdom
PL 17780/0769
11/01/2017 / 30/04/2021
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
